EBK-25028-00795
4 vaccinations
1 coded response
33 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 796 / TX
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JWU-27330-21280
Child or adolescent in my care · Male · 2022-06-28
RX2-27395-60867
Child or adolescent in my care · Male · 2022-07-13
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-09-30
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2022-04-01
-
2022-10-12
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-20
-
2022-10-26
Survey response — day 14, dose 4MedDRA: Paranasal sinus discomfort, Respiratory tract congestion — Feeling: FairFree text: Sinus pressure and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2023-01-11
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 14, dose 4
Symptoms: Sinus pressure and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release